GENETIC ENGINEERING APPRAISAL COMMITTEE (GEAC) - POLITY

News: ‘GEAC bypassing States’ right to take a call on GMO trials’: Activists

 

What's in the news?

       Anti Genetically-Modified Organism (GMO) activists have alleged that the Genetic Engineering Appraisal Committee (GEAC), the premier Central regulator that considers and decides on allowing or not allowing trials in genetic-engineering trials in the country, is subverting States’ right to take a call on the issue.

 

Genetic Engineering Appraisal Committee (GEAC):

       It is a statutory committee constituted under the “Rules for the Manufacture, Use/Import/Export and Storage of Hazardous Microorganisms/Genetically Engineered Organisms or Cells (Rules, 1989)” framed under the Environment (Protection) Act, 1986.

       It was earlier called Genetic Engineering Approval Committee, which was changed to Genetic Engineering Appraisal Committee in the year 2010.

 

Nodal Ministry:

       GEAC functions under the Ministry of Environment, Forest and Climate Change (MoEF&CC).

 

Composition:

       GEAC is chaired by the Special Secretary/Additional Secretary of MoEF&CC and co-chaired by a representative from the Department of Biotechnology (DBT).

       Presently, it has 24 members and meets every month to review the applications in the areas indicated above.

       The members comprise experts from other ministries as well as institutions such as the ICAR, ICMR, CCMB, and so on.

 

Functions:

       As per Rules, 1989, it is responsible for the appraisal of activities involving large scale use of hazardous microorganisms and recombinants in research and industrial production from the environmental angle.

       The committee is also responsible for appraisal of proposals relating to release of genetically engineered (GE) organisms and products into the environment, including experimental field trials.

       It keeps a check on the use, import, and export of genetically modified (GM) organisms and crops.

       GEAC also has the power to prohibit the manufacture and use of certain recombinants as they are hazardous for commercial use.